Thursday, January 8, 2026
Pacira reports preliminary FY25 revenue of $726.4M
Pacira BioSciences (PCRX) on Thursday reported preliminary, unaudited total revenue of $726.4 million for the year ended December 31, 2025, compared with $701.0 million for the year ended December 31, 2024. The company also repurchased 2M shares of its common stock during the fourth quarter.
https://seekingalpha.com/news/4537887-pacira-reports-preliminary-fy25-revenue-of-7264m
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.